Michael D. West
2010 - BioTime
In 2010, Michael D. West earned a total compensation of $589.2K as Chief Executive Officer at BioTime.
Compensation breakdown
| Bonus | $215,750 |
|---|---|
| Option Awards | $6,978 |
| Salary | $350,000 |
| Other | $16,500 |
| Total | $589,228 |
West received $350K in salary, accounting for 59% of the total pay in 2010.
West also received $215.8K in bonus, $7K in option awards and $16.5K in other compensation.
Rankings
In 2010, Michael D. West's compensation ranked 7,148th out of 10,439 executives tracked by ExecPay. In other words, West earned more than 31.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,148 out of 10,439 | 32nd |
Division Manufacturing | 2,623 out of 3,838 | 32nd |
Major group Chemicals And Allied Products | 626 out of 926 | 32nd |
Industry group Drugs | 423 out of 685 | 38th |
Industry Biological Products, Except Diagnostic Substances | 81 out of 147 | 45th |
Source: SEC filing on October 7, 2013.
West's colleagues
We found one more compensation record of an executive who worked with Michael D. West at BioTime in 2010.
2010
Robert Peabody
BioTime
Chief Financial Officer
News
AgeX Therapeutics CEO Michael West's 2020 pay falls 46% to $561K
November 24, 2021
AgeX Therapeutics CEO Michael West's 2019 pay falls 24% to $1M
November 24, 2020
AgeX Therapeutics CEO Michael West's 2018 pay rises 2% to $1.7M
November 29, 2019
BioTime CEO Brian Culley's 2018 pay jumps 75% to $2.8M
June 14, 2019